MDT
Medtronic plc
Healthcare • CIK 0001613103
Loading...
Market Cap
$106.80B
P/E (TTM)
22.2x
Rev Growth (TTM)
+8.4%
Net Margin (TTM)
13.2%
FCF Yield (TTM)
5.1%
FCF Margin (TTM)
14.9%
Filings your agent reads
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
10-KFY 20262 weeks agosource
8-KEarnings2026-06-03source
8-KApr 20262026-04-27source
8-KMar 20262026-03-24source
10-QQ3 20262026-02-24source
Point your agent at MDT and it navigates these the same way — citing each number back to the filing.
Cash Flow Health
Free Cash Flow8/8 positive
TTM$5.4B
Q4 '26
$2.1B-9%
Q3 '26
$2.3B+403%
FCF Margin
TTM14.9%
Q4 '2621.3%-17%
Sector: 0.0%Top 10%
OCF Margin20.2%
OCF/NI1.53x
CapEx Coverage3.8x
FCF Yield5.1%
FCF Growth (2Y)+6%
Cash Conversion Cycle
163 days
DSO: 64+DIO: 173−DPO: 74
Capital Allocation & Returns
Shareholder Friendly
Total Shareholder YieldTTM
TTM4.4%
Div Yield3.4%
+Buyback (TTM)1.0%
Strong capital returns to shareholders
Dividend & Payout Metrics
Dividend Yield (TTM)3.4%
FCF Payout Ratio67.1%
Free Cash Flow (TTM)$5.4B
Stock Repurchases (TTM)$1.0B
Capital Return / FCF86.1%
Est. Dividends Paid (TTM)$3.6B
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
6.6%
Stable
+0.0% YoY+0.4%
P25MedianP75
75th pctl (med: -0.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
14.0%
Asset Turnover
0.40x
8Q: 0.38x
Leverage (1+D/E)
1.57x
D/E: 0.57x
DuPont: 8.7% ≈ 6.6% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
5.11x
8Q:5.10x
Flat
Invested Cap Turn
0.50x
8Q:0.48x
+6.2%
CapEx Intensity
2.6%
8Q:2.6%
CapEx/Depreciation
0.64x
Asset-based ROIC formula
Valuation Analysis
Fair Value
Price-to-EarningsTTM
22.2x
Volatile
8Q: 94.3x+308%
Multiple expansion without fundamental improvement
Valuation Lenses
Earnings
22.2x
vs – sector
Cash Flow
23.4x
EV/FCF vs –
Growth-Adj
2.6xPEG
Expensive for growth
Quality-Adj
3.4P/E per %ROIC
ROIC: 6.6%
Shareholder Returns
Dividend
3.4%
Buyback
1.0%
Total Yield
4.4%
Market Cap$106.80B
EV$126.82B
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
76/100
High Quality
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)Above Avg
9.9%
8Q:–
Return on Invested Capital (ROIC)Top 25%
6.6%
8Q:–
Flat
vs Sector:-0.0%
DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)
NOPAT Margin: 14.0%
Asset Turnover: 0.40x
Earnings Quality
Cash Conversion
1.53x
OCF / Net Income ✓
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin65.0%
Capital Efficiency
Invested Capital Turnover0.50x
Working Capital
Cash Conversion Cycle163 days
Growth Quality & Momentum
Moderate Growth
Growth Quality Score
61/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%
Growth Rates
Revenue Growth YoY
8.4%
OpInc Growth YoY
30.4%
EPS Growth YoY
3.1%
FCF 3Y CAGR
5.8%
Margin Quality & Sustainability
Moderate
Profitability Cascade
Gross
65.0%
Operating
17.8%
Top 25% in sector
Net
13.2%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
+1.7 pts
FCF: 14.9% | Net: 13.2%
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Adequate
Net Debt / EBITDA
–Net Debt: $18.74B
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
0.57x
Balance sheet risk & solvency analysis